Used primarily as a potent norepinephrine-dopamine reuptake inhibitor, this compound is investigated for its potential in treating central nervous system disorders such as depression, attention deficit hyperactivity disorder (ADHD), and fatigue. Its structural selectivity enhances dopaminergic and noradrenergic transmission with minimal serotonergic activity, making it a candidate for improving focus, alertness, and mood regulation. Research also explores its application in managing substance use disorders due to its stimulant-like cognitive enhancement properties without high abuse potential. It is often utilized in preclinical studies to evaluate neurochemical pathways related to motivation and reward.